Dr. Burant to Lead Taubman Institute for Another Five-Year Term
Charles Burant, MD, PhD, first appointed Director of the Michigan Medicine Taubman Institute in 2017, will lead for an additional five-year term.
Charles Burant, MD, PhD, first appointed Director of the Michigan Medicine Taubman Institute in 2017, will lead for an additional five-year term.
Daniel Goldstein, MD and colleagues provide fundamental information about a practical therapeutic which could translate to improved outcomes in older people infected with acute respiratory viruses.
Daniel Clauw, MD and researchers find that central sensitization may be an important underlying factor complicating the treatment of comorbid chronic pain and opioid use disorder.
Sandro Cinti, MD provides an overview of monkeypox, including how it spreads, symptoms, and the best way to protect yourself.
Lauren Wallner, PhD, MPH discusses alternative models of survivorship care, patient and provider preferences, and risk-stratified care.
Pulmonary & Critical Care Medicine Division researchers evaluate measurement discrepancies by race between pulse oximetry and arterial oxygen saturation among inpatients not in intensive care.
Lindsay Petty, MD and Preeti Malani, MD are clearing up the confusion around the coronavirus drugs Paxlovid and molnupiravir.
Hallie Prescott, MD, MSc and team find that shortening the time to antibiotics administration for sepsis in 152 hospitals didn't result in antibiotic overuse.
Rodica Busui, MD, PhD; J. Michelle Kahlenberg, MD, PhD; and Subramaniam Pennathur, MD are honored with the 2022 MICHR Distinguished Clinical and Translational Research Mentor Award.
Daniel Kaul, MD discusses the first documented COVID-19 infection acquired through a transplant and the transplant team's advocacy for a national policy change.
John Osterholzer, MD; Caroline Davis, MD; and team investigate better ways to test veterans that will allow physicians to find the physical cause of their life-altering symptoms.
Megan Riehl, PsyD provides an overview of the latest innovations in psychogastroenterology delivery and which patients might be best suited for them.
Kenneth Langa, MD, PhD examines the link between individuals diagnosed with the cardiometabolic conditions diabetes, stroke, or a heart attack, and those who later developed dementia.
Imad Shureiqi, MD finds that substances touted to improve athletic performance can activate a receptor that accelerates the progression of pre-cancerous lesions to pancreatic cancer in mice.
Thomas Valley, MD, MSc discusses the ongoing need to better understand and develop pulse oximeters that work accurately in all patients.
A new ADA consensus report, chaired by Rodica Pop-Busui, MD, PhD, provides guidance on the best approaches for screening and diagnosing heart failure in individuals with diabetes or prediabetes.
Michael Ghannam, MD weighs in on what to avoid to prevent an atrial fibrillation episode.
Njira Lugogo, MD and Anna Kovalszki, MD discuss how to improve control of asthma and allergy symptoms and how to advocate for treatment.
Maria Papaleontiou, MD discusses her study that looked at the association between the intensity of thyroid hormone treatment and cardiovascular mortality.
Dina Hafez Griauzde, MD, MSc helps lead efforts to ensure that more people with obesity can reduce their risk of developing, or suffering complications from, obesity-related conditions.